Shares of the cancer diagnostics company Exact Sciences surged 25% late Wednesday, after a report said the conglomerate ...
As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...
A biennial fecal immunochemical test-based CRC screening program can increase early-stage CRC detection and short-term survival.
A recent UCLA study revealed that fewer than one in four eligible adults aged 45-49 underwent colorectal cancer screening ...
Osteoporosis occurs more commonly in women, for whom medical guidelines recommend universal screening after age 65. But about ...
Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...
UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...
UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...
More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...
"Shield" is the first FDA-approved blood test to screen for colorectal cancer. Could Trump destroy the Epstein files? I Was A ...
Brisbane-based Freenome has locked in a second major partnership for its blood-based cancer screening test, this time with a ...
Exact Sciences Corporation (EXAS) Presents at Jefferies London Healthcare Conference 2025 Transcript
Jefferies London Healthcare Conference 2025 November 18, 2025 7:30 AM ESTCompany ParticipantsKevin Conroy - Chairman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results